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ABSTRACT

Process for enriching the concentration of an enantiomer (or
a diastereomer) in a mixture of optically active isomers. The
process includes preparing a solution containing the mixture
of the optically active isomers and a chiral collector in which
the chiral collector and the enantiomer (or diastereomer) are
associated with each other. A gas is bubbled through a pool

of the solution to form a foam, the surfaces of the bubbles

in the foam having the chiral collector and the enantiomer
(or diastereomer) preferentially adsorbed thereto so that the
concentration ratio of the optically active isomers at said
bubble surfaces differs from that in the bulk of the pool. The
foam is moved vertically through a column above the pool
such that during said movement at least a portion of the
bubbles comprising the foam break thereby allowing liquid
to drain toward the pool to provide an internal reflux within
the column.

17 Claims, 5 Drawing Sheets
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2
prises forming a solution containing a mixture of optically

STEREOSELECTIVE ADSORPTIVE BUBBLE
PROCESS

active isomers and a chiral collector, with the chiral collector
being a compound having a chiral center and a structure
capable of interacting with an enantiomer or diastereomer of
the optical isomer mixture. A gas is bubbled through a pool

BACKGROUND OF THE INVENTION

The present invention relates, in general, to a process for
separating optical isomers, i.e., the enantiomers and diaste
reomers of a compound, and in particular, to a process and
apparatus for separating the optical isomers by an adsorptive
bubble technique.
Approximately 35% of all pharmaceutical products and
agrochemicals (pesticides, herbicides, etc.) are racemic mix
tures. In many instances, one of the isomers present in these
mixtures have undesired effects and limit the overall effec

tiveness of the active species. For example, one of the
isomers may present toxicity concerns, biodistribution

of the solution to form bubbles with the surfaces of the
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5

BRIEF DESCRIPTION OF THE DRAWINGS

problems, altered metabolism, and unwanted interactions.

Various techniques have been proposed to separate the
enantiomers present in these racemic mixtures. According to
one of these techniques, a diastereomeric derivative or
complex of the racemate with a pure chiral molecule
(selector) is prepared and this mixture is recrystallized
several times. Although this technique works well for some
mixtures, it tends to be tedious, time consuming and has
narrow applicability. Also, it requires one additional sepa

20
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ration step; the chiral selector (used to achieve the

separation) must be removed from the final product.
Another technique which has been proposed to separate
the enantiomers present in these racemic mixtures is bio
logical or enzymatic resolution. In this technique, microor
ganisms or enzymes are used which preferentially degrade
or react with one enantiomer of a racemate. Although
selective, this approach is practical with only a limited
number of compounds where the appropriate enzymes are
available.

Differential complexation of a variety of isomers by an
immobilized chiral stationary phase has also been proposed
for separating enantiomers from a racemic mixture. See, for
example, Armstrong, Analytical Chemistry, 59:84a-91a
(Jan. 1987) and Armstrong et al., Science, 232:1132-1135
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ment was carried out at 4° C. using permethyl-3-

cyclodextrin as the chiral collector, under total reflux con
ditions. The analytical LC chiral separations were done on a
Cyclobond I-RSP column (see Table 1 for conditions).
FIG. 3 is a series of LC chromatograms: (A) separation of
racemic warfarin starting material, (B) foam enriched prod

Example. Experiments B and C were done at room tem
perature using a 25 cm long packed foam column. The
analytical separations were done on a Cyclobond I HPLC
column (see Table 1 for conditions).

FIG. 4 shows the effect of reflux equilibration time and
concentration of the chiral collector on the enantiomeric
40

enrichment of D-N-t-BOC-phenylalanine as described in the
Example. Each curve represents a different concentration of

the permethyl-B-cyclodextrin chiral collector: (a) 1%, (b)

0.1%, (c) 0.01%, and (d) 0.05%. Experiments were done at
room temperature using a 25 cm long packed foam column.
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blockers, sedative hypnotics, antihistamines,
anticonvulsants, diuretics, and synthetic opiates. Although
this approach has applicability for a wide range of

The chiral collector was permethyl-3-cyclodextrin.

FIG. 5 shows pH dependance for the enantiomeric enrich
ment of N-t-BOC-phenylalanine as described in the
Example. The buffer was 0.01% triethylammonium acetate.

compounds, especially for analytical-scale separations,
effective scale-up to relatively large amounts (i.e., industrial
scale) is difficult, sensitive and expensive and requires
trained personnel.

DETALED DESCRIPTION OF THE
INVENTION

SUMMARY OF THE INVENTION

Among the objects of the invention, therefore, is the
provision of a process which may be used to separate optical
isomers, including, for example, optical isomers of com
mercial importance in the fields of pharmaceuticals,
pesticides, herbicides, fragrance components and clinical
analysis; the provision of such a process which may be used
to enrich such isomers in relatively large-scale; the provision
of such a process which is relatively cost-effective; the
provision of such a process which has relatively wide-scale
applicability; and the provision of an apparatus in which the
enrichment or separation may be carried out.
Briefly, therefore, the present invention is directed to an
adsorptive bubble separation process. The process com

FIG. 1 is a schematic view of a laboratory-scale apparatus
for adsorptive bubble separation of optical isomers in accor
dance with the present invention.
FIG. 2 is a LC chromatogram showing the enantiomeric
enrichment of D-N-t-BOC-phenylalanine (i.e., the second
peakin both chromatograms) using (a) a 25 or (b) a 40 cm
long foam column as described in the Example. The experi

uct using permethyl-3-cyclodextrin as a chiral collector, and
(C) foam-enriched product using heptakis(2,6-di-O-methyl)
-B-cyclodextrin as a chiral collector as described in the

(1986). In these articles, the use of immobilized

B-cyclodextrin and several other chiral stationary phases is
reported for the enrichment of numerous compounds from
such clinically useful classes as 3-blockers, calcium-channel

bubbles having the chiral collector and the enantiomer or
diastereomer preferentially adsorbed thereto so that the
concentration ratio of the optically active isomers at said
bubble surface differs from that in the bulk of the pool. The
bubbles are allowed to move vertically through the gas
space above the upper surface of the pool and they are
thereafter collapsed to form a liquid fraction which is
separate from the pool.

55
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In accordance with the present invention, it has been
discovered that effective and efficient separation of optical
isomers can be carried out by adsorptive bubble separation
techniques. Either foam fractionation, bubble fractionation,

or tandem bubble and foam fractionation systems can be
effectively utilized in the process of the present invention.
It will be understood by those skilled in the art that the
method of invention is useful for enriching and concentrat
ing optical isomers and that in many practical applications
complete quantitative isolation of one optical isomer may
not be a practical necessity. Thus, the terms "separation” and
“separating” are used herein in their accepted sense of
enrichment by modification of the optical isomer concen
tration ratio and do not necessarily imply quantitative iso
lation. Whatever the degree of separation desired, the pro
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cess of the present invention provides an effective means to
achieve it. Furthermore, although the optical isomers present
in the mixture may be enantiomers or diastereomers, other
facile techniques for separating diastereomers are known.
Without limiting the scope of the present invention,
therefore, the primary focus of the description set forth
herein will be the separation or enrichment of an enantiomer
present in a racemic mixture.
In the process of the present invention, a liquid feed
mixture is prepared comprising an aqueous solvent, a mix
ture of at least two optical isomers, and a chiral collector.
Typically, the aqueous solvent is water, but relatively small
amounts of water-miscible components (e.g., alcohols,
tetrahydrofuran, acetonitrile and salts) may be present, so
long as they do not prevent or interfere with the adsorptive
bubble fractionation process.
The chiral collector is a chiral compound which is at least
partially water soluble and which selectively associates with
an optical isomer present in the mixture. If the optical isomer
is not, itself, a surfactant the chiral collector should be a

surfactant capable of producing bubbles or a foam when
associating with the optical isomer as a gas is bubbled
through the solution. Enantioselectivity (or
diastereomerselectivity) could result either from a difference
in the association energy between the chiral collector and the
two enantiomers (or diastereomers), from a difference in the
surface adsorption of the two diastereomeric (chiral collec
tor plus enantiomer or diastereomer) complexes, or from

4
carbohydrates (native or derivatized), crown ethers, spe
cially designed synthetic compounds and combinations
thereof. In this context, derivatization means attachment of

5

mixture should be sufficient to create a continuous foam. In
10

15
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those of ordinary skill. As such, the chiral collectors have
functional groups or a structure which provide at least three
points of interaction with the optical isomer of interest. The
points of interaction may be provided, for example, by (i)
hydrogen-bonding groups such as carbonyl, hydroxyl,
amine, sulfoxide and amide groups, with hydroxyl and
amine groups being the presently preferred hydrogen
bonding groups, (ii) acidic groups such as carboxylates,
sulfonates, sulfates, phosphates, phosphonates,
phosphenates, and phenolates with carboxylic acids being
the presently preferred acidic groups, (iii) basic groups such
as protonated amines which include, for example, ammo
nium and alkyl and aryl ammonium groups, (iv) dipolar
interactive groups such as carbonyl, amide, and sulfonamide
groups, (v) aromatic rings (carbo- or heterocyclic, substi
tuted or unsubstituted) which provide TC interaction with the
optical isomer of interest, and (vi) a hydrophobic region
consisting of one or more non-polar moieties located in
close proximity to one another such as a hydrophobic cavity,
i.e., a region of the chiral collector which is generally
concave in shape (when viewed in three dimensions), is
more hydrophobic than the solution in which the chiral
collector is dissolved, and is capable of forming a complex

30
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with the isomer of interest.

In a preferred embodiment of the present invention, the
chiral collector has a sufficient number of the requisite
groups or moieties and in the proper orientation such that
simultaneous interactions can occur with chiral molecules.

Also, the chiral collector should be surface-active for most

separations. Chiral collectors falling within this class
include many derivatized cyclodextrins, amino acids (native
or derivatized), antibiotics (native or derivatized), proteins
(native or derivatized), peptides (native or derivatized),

addition, the chiral collector is preferably present in a molar
excess relative to the optical isomer with the molar ratio of
the two being in the range, for example, of about 1:1 to about
5:1 (collector:isomer). Large molar excesses of the collector
(e.g., >10:1) can result in a diminishing enrichment or yield
and are presently not preferred.
Adsorptive bubble separation is effected by passing a gas
through a pool of the liquid mixture. The gas should be
essentially inert with respect to the components of the feed
mixture. Typically, air or nitrogen may be used.
On passing of the gas through the feed mixture, bubbles
are formed and a layer of surfactant collects at the gas liquid
interface on the bubble surfaces. As previously noted, the
surfactant may be the chiral collector or the optical isomer.
In either event, the chiral collectorinteracts with at least one

of the optical isomers in the mixture and the interacting pair

become adsorbed on the bubble surfaces. As a result of the

some combination of these two factors.

The chiral collectors interact with the optical isomer via
a combination of ligand exchange interactions, charge
charge interactions, dipolar interactions, it interactions,
steric interactions, hydrophobic interactions, hydrogen
bonding interactions, or other types of interactions known to

a functional group or moiety which (i) provides one or more
points of interaction as described in detail in the paragraph
immediately preceding this paragraph, or (ii) modifies or
introduces surface-activity.
In general, the amount of chiral collector in the liquid feed

65

selectivity of the chiral collector for one of the optical
isomers or as a result of different surface adsorption
characteristics, one optical isomer is preferentially adsorbed
on the bubble surfaces. This has the effect of concentrating
at least one of the optical isomers in the foam and at least one
of the optical isomers in the liquid feed mixture, either of
which may be the isomer of interest.
Where optical isomer separation is effected by bubble
fractionation, passage of bubbles up through the liquid
mixture results in concentration of one of the optical isomers
of the mixture in a layer at the upper surface of the liquid,
while in foam fractionation, that isomer is transported from
the liquid by foam rising from the upper liquid surface.
Preferably, foam fractionation is employed and the foam
which rises from the upper liquid surface is separated from
the liquid mixture. If the optical isomer of interest is
concentrated in the foam, it is then collected by collapsing
the separated foam at a location other than the liquid surface
and separating the chiral collector from the isotope of
interest by liquid-liquid extraction, precipitation by
evaporation, or other standard techniques known to those of
ordinary skill. It is preferred that the chiral collector have a
different solubility than the optical isomer (in water or
organic solvent), different partitioning characteristics or a
different volatility to readily enable separation of the chiral
collector from the isomer. Also, it is preferred that the chiral
collector be stable through the fractionation and separation
steps of the present invention to enable recycle and reuse of
the chiral collector.

Although temperature of operation is not narrowly
critical, lower operating temperatures generally provide
greater selectivity. Depending upon the selectivity,
therefore, the process may be carried out at room tempera
ture. For some systems, however, selectivity at room tem
perature will be insufficient and temperatures of about 10°C.
or less are preferred.
Illustrated schematically in FIG. 1 is an apparatus for
separation of optical isomers by foam fractionation. The
apparatus, generally designated by reference numeral 10
comprises a column 12 disposed over a vessel 14. Within

5,629,424
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vessel 14 is a pool 16 of the liquid mixture which comprises
a chiral collector and two or more optical isomers to be
separated. Gas is introduced into pool 16 through a sparger
18 (such as a fine, porous glass frit) creating bubbles which
pass through the pool and form a foam phase 20 above the
upper surface of pool 16. The foam preferably consists of
bubbles having an average diameter of less than about 5
millimeters, more preferably less than about 3 millimeters,
and even more preferably less than about 1 millimeter. Foam
20 moves upward into column 12, contacts packing material
22 and then through a U-bend 24 into foam beaker 26 where
the foam is collapsed by allowing it to rest, adding a miscible
or immiscible solvent, heating or other conventional tech
niques. The packing material may be any conventional, inert
packing material such as glass metal or plastic beads, helices

CF
NO2

Preferably, the gasflow rate is initially adjusted so that the
foam remains equilibrating in the column under reflux
conditions for several minutes, e.g., about 5 to about 30
minutes. During this period, foam is rising from the liquid
surface and passing through the packing material.
Simultaneously, bubbles in the rising foam break thereby
releasing liquid which flows back down through the packing
material and into the pool. 16. This countercurrent process is
analogous to total reflux conditions in a fractional distilla
tion column. After this initial period, the gas flow rate is
increased and foamed solution is collected in foam beaker

CH

1
CH1
O

15

N 1

CH
CH

O

H

20

3

(SQ30,840)

CH3

O

O

CH

1s O

N1--

or coils which increase the surface area of the column and

assist in controlling the flow rate of the foam, thereby
reducing the size of the foam bubbles and the water content
of the foam. Gas is fed to sparger 18 through tube 28.

O

CH3

N-C-O -e-H

N

h

CH3
(SQ31,236)

Stock solutions of the compounds were made into stock
solutions in ethanol (or in acetonitrile for those analytes
25

analyzed using vancomycin) at a concentration of 12
mg/mL). Solutions of the chiral collector were made in
distilled water or buffer at concentrations ranging from
0.01% to 1%. One milliliter of the racemic mixture solution

30
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26. During the period in which foam is being collected,
however, partial reflux of the mixture continues with the
volume ratio of liquid moving up the column as a foam to
liquid draining toward the pool preferably being at least
about more preferably at least about 1:1, and still more

and 19 mL of chiral collector solution were placed into the
foaming chamber, and the foaming column was attached to
the sample chamber via a ground-glass joint. Air was used
to generate bubbles from the bottom of the chamber. The
height of the foamin the column was controlled by adjusting
the air flow rate with a fine control valve. In general, dry
foam formed after a period of controlled reflux gives the best
results. The glass beads also seem to help produce a finer,
slower rising foam. The foam bubbles tend to break on the
way up the column thereby producing a thin film of liquid
that flows down the column (i.e., opposite to the foam
migration). The airflow rate was adjusted so that a steady

The optical isomer of interest may be found in the
overhead product or in pool upon cessation of the bubbling
as a bottoms product. If desired, the process may be repeated
using the overhead or the bottoms product as the starting

45

countercurrent condition was produced (somewhat analo
gous to that of a fractional distillation column). At this point
nofoam passes to the receiver. Afoam fraction was collected
either by slightly increasing the flow rate to force some foam
into one receiver or by using a syringe connected to a long
thin Teflon tube on the needle to reach the top layer of the
foam in the column. In some experiments, 3 mL of a foam

solution.

50

fraction and 12 mL of fresh chiral collector solution were
used for a series of consecutive runs. Most enantiomeric

preferably at least about 5:1, 10:1, 50:1 or even 100:1.

The following example will illustrate the invention.
55

EXAMPLE

In this example, enantiomeric enrichments were obtained
for each of two different compounds using the foaming
device used shown in FIG. 1 in which the foam column was

32 cm long, the glass beads were 0.7 cm diameter, the
sample chamber could hold up to 200 ml of aqueous sample
solution, and the gas flow rate (i.e., N, or air) was controlled
via a flow control valve. The structures of the racemic

compounds resolved are as follows:

65

ratios in the foam fractions were determined by HPLC. A
Shimadzu LC6A liquid chromatography with a variable
wavelength detector and a C-R3AChromatopac data system
were used for all data analysis. The chromatographic con
ditions for the separation of all compounds studied are listed
in Table 1. The UV detection wavelength was 254 nmfor all
analytes except for the N-t-BOC amino acids, which was
225 nm. The warfarin peaks overlapped with the chiral
collector, thus solid phase extraction on a silica cartridge
was employed to remove the chiral collector before HPCL
injection. The silica cartridge was washed with 3-5 mL of
diethyl ether before the warfarin fraction was loaded, and
then warfarin was eluted from the cartridge with diethyl
ether and collected for analysis. Foam fractions of other
compounds were injected directly on the chiral stationary

5,629,424
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phase containing LC column. The enantiomeric purity of
dansyl-tryptophan and dansyl-phenylalanine were deter
mined directly on a Waters Quanta 4000 CE apparatus
equipped with a 254 nm lamp and a 50 um (i.d.)X32 cm (24

8
cm to detector) fused silica capillary. The run buffer con
tained 0.1M, pH 6 phosphate buffer plus 2 mM vancomycin
as the chiral selector.

TABLE 1.

Analytical Separation Conditions for Enantiomeric Excess Determinations
Racemate

Structure

Column Mobile Phase' or Run Buffer

warfarin

Cyclo- acetonitrile/methanol/acetic acid/

bond I triethylamine (90/10/0.004/0.004)

SQ 30,840

Cyclo- aqueous bufferlacetonitrile (80/20
bond
IRSPC

CF3

ON
H

CO2-C-(CH3)3
N

CH3

H

SQ 31,236

NO2

Cyclo- aqueous buffer/acetonitrile (85/15)
bond

ISPd

Clu H.

N1No1

C

HC

N-COOCH(CH3)2

N 1so
H

N-t-Boc-chloro-

phenylalanine

C1

Cyclo- aqueous buffer"/acetonitrile (9575)

bond

foll

IRSP.

CH-CH-NH-CO2-C(CH3)2
N-t-Boc-phenyl-

CO2H

alanine

CH-CH-NH-CO2-C(CH3)3

leucine

COOH

COOH

bond I triethylamine (90/10/04/2)

Cyclo- acetonitrile/methanol/acetic acid/

H2N-CH-CH2-CH2-S-CH3
phenylalanine'

IRSPC

Cyclo- acetonitrile/methanol/acetic acid/

H2N-CH-CH-CH(CH3)2
methionine

Cyclo- aqueous bufferlacetonitrile (93/7)

bond

CO2H
CH-CH-NH2

bond I triethylamine (96/4/0.6/1)
Cyclo- acetonitrile/methanol/acetic acid/

bond I triethylamine (90/10/04/12)

5,629,424
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TABLE 1-continued

Analytical Separation Conditions for Enantiomeric Excess Determinations
Racemate

Structure

tryptophan"

Column Mobile Phase or Run Buffer

N

Cyclo- acetonitrilelmethanol/acetic acid/

bond I triethylamine (96/4/06/1.2)

COOH

H2N-h -CH2
COOH

dansyl-tryptophan
(CH3)N

N

fused
silica

0.1Mphosphate buffer (pH 6) containing
3 mMvancomycin

fused
silica

0.1Mphosphate buffer (pH 6) containing
3 mMvancomycin

COOH

so-nt-kh-t?
Yoooh
dansylphenylalanine

(CH3)N
CH2

f
SO-NH-CH
NCOOH
Before analysis these amino acids were derivatized with AQC; fluorescent tagging agent. See S. Armstrong et al., Journal of Analytical Chem, Vol. 62, 914
(1990) for the complete procedure.
Cyclobond I refers to a 25 cm (4.6 cm i.d.) native B-cyclodextrin HPLC column.
Cyclobond IRSP refers to a 25 cm (4.6 cm i.d.) rac-hydroxypropyl-3-cyclodextrin HPLC column.

Cyclobond ISP refers to a 25 cm (4.6 cm i.d.) (S)-hydroxypropyl-B-cyclodextrin HPLC column.

This column is a 50 m (i.d.) X 32 cm (24 cm to detector) fused silica capillary used in capillary electrophoresis.
Mobile phase compositions are given as volume ratios.
The buffer consisted of 1% triethylammonium acetate (aq), pH 4.1.

The buffer consisted of 1% triethylammonium acetate (aq), pH 7.1.

General conditions for the alkylhydroxyproline and digi
tonin chiral collector experiments were as follows: 5mL of
0.02% (unless indicated otherwise) surfactant solution
(n-heptyl-L-hydroxyproline, for example) in water was
mixed with 0.25 mL of stock solutions of leucine (2
mg/mL), methionine (2.32 mg/mL), phenylalanine (2.6
mg/mL), and tryptophan (2.8 mg/mL). Approximately 4.4
mg of cupric acetate was added to the solution. When
foaming was completed, the residual solution was analyzed

meric ration of the test solute. Nine additional milliliters of
40

30840 and achieve a solution containing 81% of one enan
tiomer vs 19% of the other. In the case of SQ31236 a 2:1
enantiomeric enhancement was found.
45

Enantiomeric enrichment conditions and results using
various derivatized cyclodextrins, alkylated amino acids,
digitonin, and some antibiotics are set forth in Tables 2 and

as outlined below. All amino acids were derivatized with

(6-aminoquinolyl)-N'-hydroxysuccinimidyl carbamate
(AQC) and separated via HPLC as indicated in Table I. This
achiral derivatization procedure for amino acids and the
enantioselective separation method has been described pre
viously.
A Small aliquot of this sample was analyzed (by chiral
HPLC and/or circular dichroism) to determine the enantio

foam solution was then taken. The total solution (12 ml) was
transferred to an identical foaming device for the next cycle.
Using this procedure we were able to start with racemic SQ

3. Table 2 summarizes the data for different derivatized
50

cyclodextrin chiral collectors while Table 3 does the same

for other chiral collectors. Note that the alkylproline chiral
collectors (Table 3) were used in a "ligand exchange”
format. Hence, copper (II) salts were dissolved in solution
before foaming.
TABLE 2

Foam Flotation Conditions and Enantiomeric Enrichments Using Derivatized Cyclodextrin Collectors
Collector
Racemates

Collectors

Concentration
(G/100 mL)

warfarin

PM-3-CD
DM-B-CD
Oct-B-CD

1.
1.
1.

SQ 30,840

foaming

No. Passes

temp
(°C)

column
ht (cm)

through
column

enantioneric
ratio

ee
(%)

23
23
23

25
25
25

1.
1.
i

640
44/56
5644

20
2
2

5,629,424
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TABLE 2-continued
Foam Flotation Conditions and Enantiomeric Enrichments. Using Derivatized Cyclodextrin Collectors
Collector
foaming No. Passes
Racemates

Collectors

SQ 31,236
N-t-BOC-chlorophenylalanine
N-t-BOC-phenylalanine

Concentration

temp

column

through

enantiomeric

ee

(G/100 mL)

(°C)

ht (cm)

column

ratio

(%)

23
23
23
4.
23
4
4.
4.

25

1.

1.
1.
1.
1
1.
1.
1.

66/34
46/54
47/53
37/63
41159
18/82
1288
48/52

32

25
25
25
25
25
40
25

HP-B-CD
HP-B-CD
PM-3-CD
PM-B-CD
PM-B-CD
PM-B-CD
PM-B-CD
DM-B-CD

1

1.
0.05
0.05
0.05
0.05
O.05
0.05

8
6
26
18
64
76
4

Abbreviations: PM-B-CD = heptakis-2,3,6-tri-O-methyl-8-cyclodextrin; DM-B-CD = heptakis-2,6-di-O-methyl-8-cyclodextrin; Oct
BSP = a mixture of 8-cyclodextrin monoctyl and dioctyl esters; HP-8-CD = hydroxypropyl-B-cyclodextrin.
is is the peak area ratio of first peak/second peak.
Enantiomeric excess (ee) is defined as follows: ee = ((E-E)(E+E)) x 100%, where E is the amount of the enantiomer present

in higher concentrations and E is the amount of the enantiomer present in lower concentration.

TABLE 3
Foam Flotation Conditions and

Enantiomeric Enrichments. Using Chiral Collectors Not Related to Cyclodextrin
foaming

No. Passes

Concentration

Collector
temp

column

through

enantiomeric

(G/100 mL)

(°C.)

ht (cm)

column

ratio

ee
(%)

Race mates

Collectors

leucine

Hep-HProl
Dodec-HProl
Hep-Hprol

0.4
std soln
0.2

23
23
23

25
25
25

1.
1.

35165
46/54
4258

30
8
16

Hep-HProl
digitonin
vancomycin
vancomycin

0.2
atd soln
0.06
0.06

23
23
4
4.

25
25
25
25

1
1.
1.
1.

41159
4T153
41159
47153

18
6
18
6

methionine
phenylalanine
tryptophan
dansyl-tryptophan
dansyl-phenylalanine

Abbreviations: Hep-HProl = n-heptyl-L-hydroxyproline; Dodec-HProl = n-dodecyl-L-hydroxyproline.

This is the peak area ratio of first peak/second peak.

Enantiomeric excess (ee) is defined as follows: ee = (E - E2)/(E + E2) x 100%, where E is the amount of the enantioner
present in higher concentration and E is the amount of the enantiomer present in lower concentration.

A number of things are evident from the data presented in
Tables 2 and 3. First and foremost, it is clearly demonstrated
that enantiomeric enrichments are possible using adsorptive
bubble processes. While enantiomeric enrichments after a
single pass through the column at room temperature (ee's=
4–30) are not extraordinary, they are easily enhanced by
modifying certain experimental conditions. As can be seen
in Table 2 for N-t-BOX-chlorophenylalanine and N-t-BOC
phenylalanine, lowering the temperature of the foam flota
tion column and sample reservoir to 4° C. results in a
significant increase in the enantiomeric excess. Increasing
the length of the foam column from 25 to 40 cm also
appeared to enhance the effectiveness of the separation
(Table 2 and FIG. 2). The results for warfarin were particu
larly interesting. This was because enrichments were pro
duced with two different cyclodextrin derivatives but they
gave opposite enantiomeric selectivity (FIG. 3 and Table 2).
This was the only case where an enantioselective reversal
was observed. Enantiomeric enrichments also can be

enhanced by repeating the foam fractionation process with a
series of identical devices.

It appears that there are some similarities between the
operation of a foam fractionation column and a fractional
distillation column. For example, longer columns (Table 2)

45

and additional fractionation cycles (Tables 4 and 5) give a
more highly enriched product. The best results are obtained
in both systems when the columns are operated under
"reflux' conditions (where there is a countercurrent flow in
the column). As shown in FIG. 4, allowing the foam system
to equilibrate or reflux for a period of time (before sample
removal) enhances the enrichment process. However, after
this particular system has equilibrated for a period of time
(-25-90 min), there is no benefit (i.e., no further
enrichments) in extending the process.
TABLE 4

Effect of Repeated Passes Through a Foam Flotation
Column on the Enantiomeric Emrichment of SQ30 840

Cycle Number
Peak Area

First Peak
Second Peak
Peak Ratio

1

2.31
2.08
1.11

2

3

4.

5

6

7

8

2.44 1.39 1.22 1.18 1.23 0.82 0.68
155 0.76 0.56 0.55 0.44 0.24 0.16
1.61 1.83 2.18 2.15 2.80 3.42 4.25

Hydroxypropyl-3-cyclodextrin was used as the chiral collector (See Experi
mental Section and Table II for further experimental details.
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What is claimed is:
TABLE 5
Effect of Repeated Passes Through a Foam Flotation
Column on the Enantiomeric Enrichment of SQ 31,236

5

Cycle Number
Peak Area

First Peak
Second Peak
Peak Ratio

1. A process for enriching the concentration of an enan
tiomer or a diastereomer in a mixture of optically active
isomers, the process comprising:
preparing a solution containing the mixture of the opti
cally active isomers and a chiral collector in which the
chiral collector and the enantiomer or diastereomer are

1.

2

3

4

5

6

3.61
4.26
1.18

2.66
3.42
1.28

1.97
2.66
1.35

148
2.16
146

1.22
255
2.09

0.64
1.43
2.23

Hydroxypropyl-B-cyclodextrin was used as the chiral collector (See Experi
mental Section and Table II for further experimental details.
FIG. 4 also shows that the concentration of the chiral

collector affects the enantiomeric enrichment. There appears
to be an optimum concentration of chiral collector and
racemate for every system. The enantiomeric excess
decreases if the systemis operated with too much or too little
chiral collector. The optimum concentrations of chiral col
lector and racemate must be determined empirically. As yet
we have found no recognizable trend or theory that allows
a prediction of the best absolute and/or relative concentra

associated with each other,
O

5

internal reflux within the column.
20

tions. Another factor that affects the enantiomeric excess is

the pH of the sample solution. FIG. 5 indicates that L-N-tBOC-phenylalanine is more highly enriched at pH's near 3
than at more basic pH's. This is not surprising in view of
past enantioseparation results in reversed phase HPLC. The
pH controls the ionization state of the analyte and in some
cases of the chiral selector. Consequently, enantioselective
interactions are strongly pH dependent. It is not unusual in
HPLC and capillary electrophoresis for an enantiomeric
separation to occur at one pH and not at another. Clearly,
optimization of the pH can be as important in foamflotation
as in most other water-based enantioseparation techniques.
In general, factors that appeared to affect this water-based
separation include the following: (a) column length, (b)
column geometry and packing, (c) gas flow rate, (d) column
geometry and packing, (c) gas flow rate, (d) concentration of
the chiral collector and the racenate, (e) nature of the chiral
collector, (f) temperature, (g) pH, (h) reflux time, (i) foam
dryness, and (j) the presence of other materials in the sample
(e.g., miscible organic solvents, salts, etc.).

Materials. Heptakis(2,6-di-O-methyl)-3-cyclodextrin was
purchased from Sigma (St. Louis, Mo.), permethyl-3cyclodextrin was obtained from Cyclolab R&D Laboratory
(Budapest, Hungary), and hydroxypropyl-3-cyclodextrin

25

30

5. The process of claim 1 wherein the foam exits the
column and is collected as an overhead product and, as the
foam exits the column, the volume ratio of liquid moving up
the column as a foam to liquid draining toward the pool is
at least about 1:1.

35

6. The process of claim 1 wherein the foam exits the
column and is collected as an overhead product and, as the
foam exits the column, the volume ratio of liquid moving up
the column as a foam to liquid draining toward the pool is
at least about 5:1.

7. The process of claim 1 wherein the foam exits the
column and is collected as an overhead product and, as the
foam exits the column, the volume ratio of liquid moving up
the column as a foam to liquid draining toward the pool is
at least about 10:1.
45

8. The process of claim 1 wherein the foam exits the
column and is collected as an overhead product and, as the
foam exits the column, the volume ratio of liquid moving up
the column as a foam to liquid draining toward the pool is
at least about 50:1.

50

9. The process of claim 1 wherein the foam exits the
column and is collected as an overhead product and, as the
foam exits the column, the volume ratio of liquid moving up
the column as a foam to liquid draining toward the pool is
at least about 100:1.
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10. A process for enriching the concentration of an
enantiomer in a mixture of optical isomers, the process
comprising:
preparing a solution containing the mixture of the opti
cally active isomers and a chiral collector in which the
chiral collector and the enantiomer are associated with

each other and in which there are simultaneously at
least 3 points of interaction between the chiral collector

In view of the above, it will be seen that the several

objects of the invention are achieved.
As various changes could be made in the above compo
sitions and processes without departing from the scope of
the invention, it is intended that all matter contained in the
above description be interpreted as illustrative and not in a
limiting sense.

2. The process of claim 1 wherein the column is packed
with a packing material.
3. The process of claim 1 wherein the column is packed
with glass, plastic or metal spheres, helices or coils.
4. The process of claim 1 wherein the foam exits the
column and is collected as an overhead product and, as the
foam exits the column, the volume ratio of liquid moving up
the column as a foam to liquid draining toward the pool is
at least about 1:5.

was obtained from Consortium. FurElektrochemische Indus

trie GMBH. Significantly, no commercial derivatized cyclo
dextrins are pure; they are composed of mixtures of homo
logues and isomers. Warfarin, D- and L-N-t-BOC
phenylalanine, D- and L-N-t-BOC-chlorophenylalanine,
dansyl-D.L-tryptophan, dansyl-D,L-phenylalanine,
N-heptyl-L-hydroxyproline, Vancomycin, and digitonin
were purchased from Sigma. SQ30,840 and SQ31.236 were
obtained from Squibb (New Brunswick, N.J.). All solvents
were obtained from Fisher Scientific (Fair Lawn, N.J.). The
silica cartridges for solid phase extraction were purchased
from Alltech (Deerfield, Ill.). All HPLC columns were
obtained from Advanced Separation Technology Inc.
(Whippany, N.J.). Pyrex gas dispersion tubes and other
glassware were obtained from Fisher Scientific.

bubbling a gas through a pool of the solution to form a
foam, the surfaces of the bubbles in the foam having the
chiral collector and the enantiomer or diastereomer
preferentially adsorbed thereto so that the concentra
tion ratio of the optically active isomers at said bubble
surfaces differs from that in the bulk of the pool,
moving said foam vertically through a column above the
pool such that during said movement at least a portion
of the bubbles comprising the foam break thereby
allowing liquid to drain toward the pool to provide an

and the enantiomer,

65

bubbling a gas through a pool of the solution to form
bubbles, the surfaces of the bubbles having the chiral
collector and the enantiomer preferentially adsorbed
thereto so that the concentration ratio of the optical
isomers at said bubble surface differs from that in the

bulk of the pool, and
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moving said bubbles vertically through the area above the
bubbling a gas through a pool of the solution to form a
upper surface of the pool.
foam, the surfaces of the bubbles of the foam having an
11. The process of claim 10 wherein the chiral collector
inclusion complex of the chiral collector and the enan
has surface-active properties.
tiomer
preferentially adsorbed thereto, so that the con
12. The process of claim 10 wherein after said moving
centration
ratio of the optically active isomers at said
step, the bubbles are recovered as an overhead product
bubble
surfaces
differs from that in the bulk of the pool,
containing a mixture of optical isomers which is enriched in
and
one of the enantiomers as compared to the starting solution,
the bubbles in the overhead product are collapsed, and the
moving said foam vertically through the gas-space above
fractionation process of claim 1 is repeated using a solution 10
the upper surface of the pool.
which is prepared from the overhead product.
17. A process for enriching the concentration of an
13. The process of claim 12 wherein the process of claim enantiomer or a diastereomer in a mixture of optically active
12 is repeated at least once.
14. The process of claim 10 wherein after said moving isomers, the process comprising:
step, the pool is recovered as a bottoms product containing 15 preparing a solution containing the mixture of the opti
cally active isomers and a chiral collector in which the
a mixture of optical isomers which is enriched in one of the
chiral collector and the enantiomer or diastereomer are
enantiomers or diastereomers as compared to the starting
solution, and the fractionation process of claim 1 is repeated
associated with each other,
using a solution which is prepared from the bottoms product.
bubbling
a gas through a pool of the solution to form
15. The process of claim 14 wherein the process of claim 20
bubbles,
the surfaces of the bubbles having the chiral
14 is repeated at least once.
collector
and the enantiomer or diastereomer preferen
16. A process for enriching the concentration of an
tially adsorbed thereto so that the concentration ratio of
enantiomer in a mixture of optically active isomers, the
the optically active isomers at said bubble surface
process comprising:
differs from that in the bulk of the pool,
25
preparing a solution containing the mixture of the opti
moving
said bubbles vertically through the gas-space
cally active isomers and a chiral collector in which the
above the upper surface of the pool, and
chiral collector and the enantiomer are associated with
each other and in which there are simultaneously at
thereafter recovering the optical isomer of the mixture
least 3 points of interaction between the chiral collector
from the pool which is present in the greatest quantity.
and the enantiomer with one of the points of interaction 30
:k
k -k sk. ::
involving a hydrophobic region of the chiral collector,

